Clinical trial
Clozapine and Olanzapine in the Treatment of Violence in Schizophrenic Patients
NCT01123408 is registered in ClinicalTrials.gov with Nathan Kline Institute for Psychiatric Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clozapine and Olanzapine in the Treatment of Violence in Schizophrenic Patients
- Lead sponsor
- Nathan Kline Institute for Psychiatric Research
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 1999
- Completion date
- July 31, 2004
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.